Literature DB >> 10188929

Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein.

G R Dawson1, G R Seabrook, H Zheng, D W Smith, S Graham, G O'Dowd, B J Bowery, S Boyce, M E Trumbauer, H Y Chen, L H Van der Ploeg, D J Sirinathsinghji.   

Abstract

Mutations in the beta-amyloid precursor protein are strongly associated with some cases of familial Alzheimer's disease. The normal physiological role of beta-amyloid precursor protein in the brain was evaluated in a cross-sectional analysis of mice deficient in beta-amyloid precursor protein. Compared with wild-type control mice the beta-amyloid precursor protein-null mice developed age-dependent deficits in cognitive function and also had impairments in long-term potentiation. In addition, the brains of the beta-amyloid precursor protein-null mice had marked reactive gliosis in many areas, especially in the cortex and hippocampus. A subpopulation of mice (n = 15) died prematurely (between three and 18 months of age). Analysis of another six mice from the same population that were showing weight loss and hypolocomotor activity exhibited a marked reactive gliosis as detected by immunoreactivity for glial fibrillary acidic protein and a profound loss of immunoreactivities for the presynaptic terminal vesicle marker proteins synaptophysin and synapsin and the dendritic marker microtubule-associated protein-2 in many brain areas, but most predominantly in the cortex and hippocampus. These results suggest that normal beta-amyloid precursor protein may serve an essential role in the maintenance of synaptic function during ageing. A compromise of this function of the beta-amyloid precursor protein may contribute to the progression of the memory decline and the neurodegenerative changes seen in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10188929     DOI: 10.1016/s0306-4522(98)00410-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  120 in total

1.  Beta amyloid-independent role of amyloid precursor protein in generation and maintenance of dendritic spines.

Authors:  K J Lee; C E H Moussa; Y Lee; Y Sung; B W Howell; R S Turner; D T S Pak; H S Hoe
Journal:  Neuroscience       Date:  2010-05-06       Impact factor: 3.590

Review 2.  Functions of the APP gene family in the nervous system: insights from mouse models.

Authors:  Dorothee Aydin; Sascha W Weyer; Ulrike C Müller
Journal:  Exp Brain Res       Date:  2011-09-20       Impact factor: 1.972

3.  Functional consequences of the lack of amyloid precursor protein in the mouse dentate gyrus in vivo.

Authors:  Peter Jedlicka; Mirka Owen; Matej Vnencak; Jakob-A Tschäpe; Meike Hick; Ulrike C Müller; Thomas Deller
Journal:  Exp Brain Res       Date:  2011-11-11       Impact factor: 1.972

Review 4.  Synaptic plasticity in animal models of early Alzheimer's disease.

Authors:  Michael J Rowan; Igor Klyubin; William K Cullen; Roger Anwyl
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-04-29       Impact factor: 6.237

5.  Deficits in axonal transport in hippocampal-based circuitry and the visual pathway in APP knock-out animals witnessed by manganese enhanced MRI.

Authors:  Joseph J Gallagher; Xiaowei Zhang; Gregory J Ziomek; Russell E Jacobs; Elaine L Bearer
Journal:  Neuroimage       Date:  2012-02-10       Impact factor: 6.556

Review 6.  Amyloid-β peptide: Dr. Jekyll or Mr. Hyde?

Authors:  Daniela Puzzo; Ottavio Arancio
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 7.  The upside of APP at synapses.

Authors:  Hyang-Sook Hoe; Hey-Kyoung Lee; Daniel T S Pak
Journal:  CNS Neurosci Ther       Date:  2010-12-27       Impact factor: 5.243

8.  Age-related decreases in SYN levels associated with increases in MAP-2, apoE, and GFAP levels in the rhesus macaque prefrontal cortex and hippocampus.

Authors:  Gwendolen E Haley; Steven G Kohama; Henryk F Urbanski; Jacob Raber
Journal:  Age (Dordr)       Date:  2010-04-13

Review 9.  Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.

Authors:  Meaghan C Creed; Norton W Milgram
Journal:  Age (Dordr)       Date:  2010-04-20

10.  Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity.

Authors:  Huifang Ma; Sylvain Lesné; Linda Kotilinek; Jill V Steidl-Nichols; Mathew Sherman; Linda Younkin; Steven Younkin; Colleen Forster; Nicolas Sergeant; André Delacourte; Robert Vassar; Martin Citron; Paulo Kofuji; Linda M Boland; Karen H Ashe
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.